Article

Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+ vascular progenitors.

Department of Immunology, Imperial College London, Hammersmith Hospital, London, UK.
Blood (impact factor: 9.9). 05/2008; 111(8):4155-64. DOI:10.1182/blood-2007-10-120295 pp.4155-64
Source: PubMed

ABSTRACT Tissue factor (TF) and thrombin are involved in intimal hyperplasia (IH) and remodelling following vascular injury. Because many neointimal smooth muscle cells (VSMCs) derive from circulating vascular progenitors (VPs), we investigated how thrombin influences VP phenotype and function. Following wire-induced carotid artery injury in mice, the majority of circulating VPs expressed TF, were capable of initiating clotting in vitro, and had protease-activated receptors (PAR)-1, -2, and -4. Thrombin, through PAR-1, inhibited apoptosis and caused proliferation, resulting in the outgrowth of VP coexpressing markers of activated endothelial cells and VSMCs, even in the presence of growth factors. These mixed-phenotype VPs circulated as a minority population after injury and shared a similar phenotype with many neointimal cells. Labeled CD34(+) cells, injected up to 2 weeks after injury, could be detected in the injured vessel wall, suggesting that continued recruitment may contribute to progressive IH. Finally, CD34(+) cells incubated with thrombin prior to injection promoted florid neointimal lesions, whereas those incubated with PAR antagonists inhibited IH and promoted regenerative repair characterized by the development of a quiescent endothelium. We conclude that IH after vascular injury is due to the direct actions of thrombin on mobilized VPs.

0 0
 · 
0 Bookmarks
 · 
19 Views

Keywords

activated endothelial cells
 
continued recruitment
 
direct actions
 
florid neointimal lesions
 
inhibited apoptosis
 
injured vessel wall
 
intimal hyperplasia
 
minority population
 
mixed-phenotype VPs
 
neointimal cells
 
neointimal smooth muscle cells
 
outgrowth
 
PAR antagonists inhibited IH
 
protease-activated receptors
 
Thrombin
 
thrombin influences VP phenotype
 
vascular injury
 
VP coexpressing markers
 
VPs
 
wire-induced carotid artery injury